Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Changlu Zhang
PEA‑15 Contributes to the Clinicopathology and AKT‑regulated Cisplatin Resistance in Gastric Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Evaluation of Third-Party Reverse Logistics Providers Based on Extension Superiority Method
Ingenierie des Systemes d'Information
Information Systems
Related publications
LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway
Cancer Management and Research
Oncology
Dampened PI3K/AKT Signaling Contributes to Cancer Resistance of the Naked Mole Rat
SIRT1 Contributes in Part to Cisplatin Resistance in Cancer Cells by Altering Mitochondrial Metabolism
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Effects of Taxol Resistance Gene 1 on the Cisplatin Response in Gastric Cancer
Oncology Letters
Cancer Research
Oncology
Akt-Regulated Pathways in Prostate Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
RNF138 Confers Cisplatin Resistance in Gastric Cancer Cells via Activating Chk1 Signaling Pathway
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
AFAP1‑AS1 Induces Cisplatin Resistance in Non‑small Cell Lung Cancer Through PI3K/AKT Pathway
Oncology Letters
Cancer Research
Oncology
PKM2 Promotes Cell Migration and Inhibits Autophagy by Mediating PI3K/AKT Activation and Contributes to the Malignant Development of Gastric Cancer
Scientific Reports
Multidisciplinary
LncRNA TATDN1 Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Through TATDN1/miR-451/TRIM66 Axis
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
